AWH aspirawh.com: Business Value to Revenue

Official company branding of Aspira Women's Health Inc. (AWH)

Is it worth investing in Aspira Women's Health (AWH), which attracts leading bioinformaticians with its mission? The GURU.Markets platform broadcasts the business's price-to-sales ratio, where the level of is the current value. The humanitarian status of biomedicine guarantees the company's stability, although global crises may temporarily increase the cost of logistics for laboratory consumables.

AWH Aspira Women's Health Inc Company Value to Revenue (07/04/2022 - 11/20/2026)

AWH (aspirawh.com): analytical breakdowns and indicator data

- market price and analyst price targets:
- company stock capitalization data:
Initial company analysis:Aspira Women's Health
Manufactured product of Aspira Women's Health

Institutional capital evaluates Aspira Women's Health (AWH) through the lens of the scalability of its AI algorithms and OvaSuite testing systems, determining a fair premium for its technological leadership. By analyzing the business value relative to revenue, the investor compares total assets and liabilities against annual turnover, which allows for the identification of asset overbought conditions and the determination of a safe entry point for the position.

Competitor analysis for Aspira Women's Health

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple CDIO (Cardio Diagnostics)|ONCO - Company Value to Revenue|VRAX: Company Value to Revenue|bluejaydx.com (BJDX) - Company Value to Revenue|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue